A detailed history of Lpl Financial LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 26,236 shares of BEAM stock, worth $663,508. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,236
Previous 26,432 0.74%
Holding current value
$663,508
Previous $619,000 3.72%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$22.57 - $33.14 $4,423 - $6,495
-196 Reduced 0.74%
26,236 $642,000
Q2 2024

Aug 07, 2024

BUY
$21.22 - $32.66 $53,813 - $82,825
2,536 Added 10.61%
26,432 $619,000
Q1 2024

May 10, 2024

BUY
$23.46 - $45.07 $50,016 - $96,089
2,132 Added 9.8%
23,896 $789,000
Q4 2023

Feb 14, 2024

BUY
$17.69 - $30.76 $98,639 - $171,517
5,576 Added 34.45%
21,764 $592,000
Q3 2023

Nov 13, 2023

SELL
$23.01 - $32.46 $272,231 - $384,034
-11,831 Reduced 42.22%
16,188 $389,000
Q2 2023

Jul 31, 2023

BUY
$29.32 - $35.99 $132,966 - $163,214
4,535 Added 19.31%
28,019 $894,000
Q1 2023

May 10, 2023

BUY
$30.15 - $48.79 $171,161 - $276,980
5,677 Added 31.88%
23,484 $719,000
Q4 2022

Feb 07, 2023

BUY
$36.73 - $51.6 $106,774 - $150,001
2,907 Added 19.51%
17,807 $696,000
Q3 2022

Nov 14, 2022

SELL
$39.79 - $70.31 $259,152 - $457,929
-6,513 Reduced 30.42%
14,900 $710,000
Q2 2022

Aug 12, 2022

BUY
$29.86 - $62.36 $93,163 - $194,563
3,120 Added 17.06%
21,413 $829,000
Q1 2022

May 16, 2022

BUY
$53.73 - $82.16 $207,827 - $317,794
3,868 Added 26.81%
18,293 $1.05 Million
Q4 2021

Feb 14, 2022

SELL
$68.02 - $99.06 $171,954 - $250,423
-2,528 Reduced 14.91%
14,425 $1.15 Million
Q3 2021

Nov 15, 2021

BUY
$84.37 - $133.6 $2,615 - $4,141
31 Added 0.18%
16,953 $1.48 Million
Q2 2021

Aug 13, 2021

BUY
$64.12 - $128.71 $703,396 - $1.41 Million
10,970 Added 184.31%
16,922 $2.18 Million
Q1 2021

May 14, 2021

BUY
$71.28 - $120.75 $158,312 - $268,185
2,221 Added 59.53%
5,952 $476,000
Q4 2020

Feb 12, 2021

BUY
$22.24 - $95.63 $82,977 - $356,795
3,731 New
3,731 $305,000

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.78B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.